References
- SalamaHAhmadHElchageaIAmbovex® as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trialJ Hepatocell Carcinoma20152798927508197
- BaloghJVictorDAshamEHHepatocellular carcinoma: a reviewJ Hepatocell Carcinoma20163415327785449
- ShiJKellerJMZhangJKellerETA review on the diagnosis and treatment of hepatocellular carcinoma with a focus on the role of Wnts and the dickkopf family of Wnt inhibitorsJ Hepatocell Carcinoma201411727508171
- KewMHepatocellular carcinoma: epidemiology and risk factorsJ Hepatocell Carcinoma2014111512527508181
- ElsayesKMKielarAZAgronsMMLiver imaging reporting and data system: an expert consensus statementJ Hepatocell Carcinoma20174293928255543
- El-KhoueiryABSangroBYauTNivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trialLancet2017389100882492250228434648